Top Markets
#1 Seeker Seeker +129.13%
#2 MowCat MowCat +107.71%
#3 AI XOVIA AI XOVIA +105.43%
#4 Helium Helium +86.38%
#5 Pons Pons +55.10%
#6 UnifAI Network UnifAI Network +34.96%
#7 Zora Zora +31.04%
#8 Bounce Bounce +21.20%
#9 Zylo Ecosystem Zylo Ecosystem +21.16%
#10 Tensor Tensor +18.98%
Coin of the day
Seeker Seeker
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
Jacobio Pharmaceuticals Group Co., Ltd. Jacobio Pharmaceuticals Group Co., Ltd.

Jacobio Pharmaceuticals Group Co., Ltd.

1167
Helyezés a részvények között #11796
Jacobio Pharmaceuticals Group Co., Ltd. is a clinical-stage pharmaceutical firm... Jacobio Pharmaceuticals Group Co., Ltd. is a clinical-stage pharmaceutical firm specializing in the proprietary discovery and development of oncology therapies. Its primary drug development initiatives feature two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors, JAB-3312 and JAB-3068, which are being investigated for esophageal cancer. Also in development is JAB-8263, a small molecule designed to inhibit BET family proteins that regulate MYC transcription, aiming to treat a range of cancers, alongside JAB-21822, an oral small molecule specifically targeting the mutant KRAS G12C protein. Jacobio is further advancing JAB-BX102, a humanized inhibitory antibody against human CD73, intended for treating PD-1 resistant cancers. Other pipeline assets include JAB-6343, an inhibitor targeting fibroblast growth factor receptor 4 for advanced hepatocellular carcinoma exhibiting FGF19 overexpression; JAB-2485, an aurora A kinase inhibitor for solid tumors; JAB-24114, which targets a tumor metabolic pathway for solid tumor treatment; and JAB-BX300, a molecular antibody designed to target the RAS pathway for pancreatic and other solid tumors with KRAS mutations. The company maintains a strategic partnership with AbbVie Ireland Unlimited Company for the development and commercialization of SHP2 inhibitors. Established in 2015, Jacobio Pharmaceuticals is headquartered in Beijing, China.
Részvényárfolyam
$0.84111496
Utolsó szinkronizálás: 2026-08-28
Piaci kapitalizáció
$657.90M
Változás (1 nap)
-0.75%
Változás (1 év)
-19.13%
Ország
CN
Kereskedés Jacobio Pharmaceuticals Group Co., Ltd. (1167)

Kategória

Healthcare
Jacobio Pharmaceuticals Group Co., Ltd. (1167) részvényárfolyamának története
Legmagasabb napi záróár: $0.70 ekkor: 2026-08-01

Legalacsonyabb napi záróár: $1.84 ekkor: 2020-12-01
Jacobio Pharmaceuticals Group Co., Ltd. részvényárfolyamának története 2020 és 2026 között
Éves részvényárfolyam teljesítmény
Év Teljesítmény
2026 (TTM) -15.43%
2025 484.68%
2024 -61.65%
2023 -33.34%
2022 -61.78%
2021 -1.98%
2020 0.00%
Hasonló cégek vagy versenytársak részvényárai
Vállalat Részvényár Változás 1év% Ország
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH